Associate Director, Hypercell, Data Engineer at Bristol-Myers Squibb

Devens, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Cell TherapyIndustries

Requirements

Bachelor’s or Master’s degree in Computer Science, Data Engineering, Information Systems, or related field
7-10+ years of experience in data engineering, preferably in biopharma, cell therapy, or regulated manufacturing environments
Strong proficiency in SQL, Python, and data pipeline frameworks (e.g., Apache Airflow, DBT)
Experience with cloud platforms (e.g., AWS, Azure, GCP) and data warehousing solutions (e.g., Snowflake, Redshift)
Familiarity with GMP data requirements and regulatory expectations for data integrity
Proven ability to work cross-functionally and translate business needs into technical solutions
Preferred Qualifications
Experience supporting AI/ML initiatives through data engineering and model deployment
Knowledge of manufacturing systems (e.g., MES, LIMS, ERP) and integration strategies
Familiarity with visualization tools (e.g., Power BI, Tableau) and self-service analytics platforms
Strong communication skills

Responsibilities

Design, build, and maintain scalable data pipelines and data models to support Hypercell’s digital and AI initiatives
Collaborate with BI&T and process engineering teams to define and implement data hierarchies that enable automated report generation from source systems
Integrate structured and unstructured data from manufacturing, quality, and digital platforms into unified, accessible formats
Support the development and deployment of AI-facing tools, ensuring data readiness, integrity, and traceability
Partner with data scientists and engineers to enable advanced analytics, predictive modeling, and process optimization
Ensure data governance, security, and compliance with internal and external regulatory requirements
Troubleshoot data-related issues and implement solutions to improve data reliability and performance
Contribute to the development of dashboards, visualizations, and self-service tools for end users across the business

Skills

Data Engineering

Data Pipelines

Data Models

Scalable Data Infrastructure

Data Integration

Automation

Analytics

Automated Reporting

ETL

SQL

Python

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free